SynthesisImmunotherapy2017

Anti-CD 19 and anti-CD 20 CAR-modified T cells for B-cell malignancies: a systematic review and meta-analysis.

Irbaz Bin Riaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.